| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $296.5M | +35.1% |
| R&D Expense | $40.6M | +36.1% |
| SG&A Expense | $76.5M | -24.5% |
| Operating Income | -$41.1M | +49.8% |
| Pre-tax Income | -$36.4M | +55.4% |
| Income Tax | $133K | +102.2% |
| Net Income | -$36.6M | +51.6% |
| EPS (Basic) | -$0.51 | +54.1% |
| EPS (Diluted) | -$0.51 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $154.2M | -10.9% |
| Accounts Receivable | $44.0M | +6.2% |
| Inventory | $14.3M | +27.3% |
| Current Assets | $248.6M | +2.3% |
| Total Assets | $1.16B | -2.6% |
| Current Liabilities | $62.6M | -2.4% |
| Total Liabilities | $81.2M | -11.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.5M | +123.8% |
| Capital Expenditures | $8.5M | +59.0% |
| Investing Cash Flow | -$29.4M | +96.0% |
| Financing Cash Flow | $3.5M | -99.4% |
| Free Cash Flow | -$1.0M | +97.3% |
| +54.1% |
| Stockholders' Equity |
| $1.08B |
| -1.9% |